Naveed Saleh, MD, MS
Atezolizumab is an immune checkpoint inhibitor that has been approved by the US Food and Drug Administration in various combinations for a number of cancer types in recent years. Here is a closer look at this important drug and its expanding uses.
Naveed Saleh, MD, MS Prostate cancer is the most frequent cancer found in American men, and the second leading cause of cancer death in this population. Currently, scores of reputable clinical trials are underway and recruiting patients.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: MultiMedia Healthcare
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA
